The National Cancer Institute (NCI) has renewed its Cancer Center Support Grant to Dartmouth and Dartmouth-Hitchcock Norris Cotton Cancer Center (NCCC). The 5-year, $15.5 million grant will provide continued support for NCCC’s clinical care and research missions. NCI recognized the cancer center for its leadership and resources, in addition to demonstrating an added depth and breadth of research and substantial transdisciplinary research that bridges basic science and clinical research.
Steven Leach, MD
“I am incredibly proud of the work done by NCCC’s passionate and committed clinicians and researchers in reaching this milestone,” said NCCC Director Steven Leach, MD. “In renewing our grant and our designation, the NCI has recognized that NCCC provides the same level of cancer care and research as a major metropolitan Comprehensive Cancer Center, but with a small town, compassionate community face.”
The funding under the NCI renewal will support advances in immunotherapy, discovery of new treatments, and advances in devices and imaging techniques that will lead to improved outcomes for patients at NCCC. It will also enable outreach to rural populations and better understanding of the particular needs of those patients on the cancer journey. Many of the advances developed by the clinicians and scientists through previous NCI grant funding have led to specific small business grants from the NCI. This funding is one of the many sources to provide the $55 million in additional support for research awarded to members of the cancer center.
NCCC is among 51 centers in the United States to be recognized as an NCI-designated Comprehensive Cancer Center.